Tagged Articles

attorneys 490 articles

Plaintiffs allege Johnson & Johnson Avoided Standard Regulatory Review of metal-on-metal hip implants


In a multidistrict litigation (MDL) bellwether trial over metal-on-metal hip implants made by Johnson & Johnson‘s subsidiary, DePuy Orthopaedics, a lead plaintiff attorney told a Texas federal jury that the medical device manufacturing giant “evaded standard regulatory review and convinced doctors a dangerous design was safe.” The MDL is made up of 8,500 cases. Six patients involved in the current trial were forced to undergo revision surgeries after receiving a metal-on-metal hip system. The device consisted of a metal ball and metal socket that rubbed together during normal use, allegedly causing microscopic metallic particles to flake off the device and pollute ... Read More

Wrongful death lawsuit involving AndroGel testosterone to remain in state court


A wrongful death lawsuit against AbbVie Inc. involving its top selling AndroGel testosterone treatment will remain in state court, a California federal judge ruled, rejecting the drug company’s bid to hold off on until the case can be transferred to a multidistrict litigation (MDL) in Illinois. Evelyn Calvillo filed her lawsuit against AbbVie and the California-based distributor McKesson Corp., in Orange County Superior Court in July, alleging her husband died after using the testosterone replacement therapy. AbbVie argued that Calvillo had included McKesson in the lawsuit only to anchor her suit in California and that McKesson was not a suitable ... Read More

Plaintiffs attorneys request consolidation of 56 Invokana lawsuits


Attorneys representing patients suing Johnson & Johnson and its subsidiaries alleging kidney injuries with its type 2 diabetes drug Invokana asked a Judicial Panel on Multidistrict Litigation to consolidate into New Jersey federal court 56 lawsuits currently in 11 different federal districts. Leaving them separate, attorneys argued, would be highly inefficient since they largely involve the same discovery, documents and depositions. New Jersey was suggested as the appropriate place for the multidistrict litigation (MDL) to be consolidated since Johnson & Johnson is located in New Brunswick, N.J., and the codefendant, Janssen Pharma, is in neighboring Titusville. Plaintiffs attorneys also argued ... Read More

Number of Xarelto lawsuits growing


Patients who require blood-thinning medications to treat or prevent blood clot-related health conditions should discuss with their doctors the risks and benefits of the various types of treatments, advised Dr. Rita Redberg, a professor of cardiology at the University of California, San Francisco. “There are now several new oral anticoagulants and we don’t have a lot of studies that compare one to the other,” she said. Millions of patients are diagnosed with the heart rhythm abnormality atrial fibrillation, and most are treated with blood thinners to prevent strokes. For decades, doctors have prescribed warfarin. But patients taking the drug require ... Read More

Talc trial: ‘Just a warning on the bottle’ might have spared plaintiff complications from ovarian cancer treatments

talc ovarian cancer

Tuesday St. Louis jurors began to be presented with evidence in the third talc trial this year against Johnson and Johnson. According to Law360., in the opening arguments jurors were introduced to the plaintiff Deborah Giannecchini, who was diagnosed with Stage 4 ovarian cancer. Complications from her treatment have greatly reduced her life expectancy. “She has literally had her spleen removed, part of her stomach removed, part of her colon removed, all of her ovaries, uterus. She has literally had basically the lower half of her body removed,” said R. Allen Smith, Jr., one of the lead attorneys in the ongoing talc litigation. “She ... Read More

Jurors selected in third talc trial of the year

talc ovarian cancer

In an update from CBS St. Louis, the pool of 50 jurors in the third talc case to be tried in St. Louis this year should have been narrowed down to 12 plus alternates, and opening arguments are beginning. Johnson and Johnson has been working hard behind the scenes to hinder the advent of this trial. Earlier in the summer Johnson and Johnson attempted twice to have the trial removed to 100 miles away from St. Louis, claiming that the number of talcum powder litigation ads broadcast in the St. Louis area would deprive them of a fair trial. Then ... Read More

Judge extends deadline for filing Xarelto lawsuits


The deadline for filing Xarelto lawsuits alleging bleeding injuries with the popular blood thinner has been extended 90 days for certain plaintiffs groups due to an influx of complaints that have reportedly inundated the clerk’s office, Judge Eldon Fallon ordered. Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer are facing more than 7,000 lawsuits in a multidistrict litigation alleging the companies’ blood thinner Xarelto caused major bleeding events including gastrointestinal bleeds and brain hemorrhages. Four bellwether trials have already been scheduled for 2017. Another 950 lawsuits have been consolidated into a mass tort program in Pennsylvania with the first scheduled ... Read More

35 states file antitrust lawsuit against drug companies alleging unlawful marketing of addiction treatment


Thirty-five states and the District of Columbia are accusing British drugmaker Indivior of unlawfully manipulating the marketplace to maximize profits when it allegedly conspired to keep less expensive, generic versions of the narcotic addiction treatment Suboxone off the market, California’s attorney general announced. The states filed an antitrust lawsuit in the U.S. District Court for the Eastern District of Pennsylvania against Indivior and MonoSol Rx, a New Jersey-based pharmaceutical dissolving-film company. In 2002, Indivior was granted exclusive rights to market Suboxone tablets until 2009. When the patent expired, the attorneys general claim that Indivior worked out a deal with MonoSol ... Read More

J&J thwarted in attempt to postpone talc trial starting this week

talc ovarian cancer

The third state court trial over the alleged ovarian cancer risks of Johnson and Johnson’s talc powder products is scheduled for Monday, Sep. 26 in Missouri. Jury selection should begin this week. The trial was almost postponed when Johnson and Johnson tried to have the trial removed to federal court. In 2014, J&J had attempted to have the same batch of 45 cases removed from state court for the same reasons, claiming that the cases were “fraudulently misjoined in an effort to defeat diversity jurisdiction.” Both in 2014 and last Wednesday, Sept. 21, U.S. District Judge Jean C. Hamilton found that the ... Read More

Health site warns readers of drugs involved in major lawsuits; Nexium makes the list


Health and Fitness Cheatsheet acknowledges that many of its readers may find it necessary to be on prescription medication. With that necessity comes many anxieties over their health and the safety of the medications they are taking. The health site recently featured an article that addresses its readers’ worries that their medication might be causing major lawsuits, and what that might mean for them. “…it can be extremely troubling when you see that your prescribed medication is causing a major lawsuit. You may feel as though you’re putting your own life at risk. With so many prescription drugs out there, ... Read More